Natsumeda M et al. |
Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy. |
2014 |
Acta Neuropathol Commun |
pmid:25376594
|
Chittaranjan S et al. |
Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity. |
2014 |
Oncotarget |
pmid:25277207
|
Liu Z et al. |
Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure-activity relationship, and selective antitumor activity. |
2014 |
J. Med. Chem. |
pmid:25271760
|
Shim EH et al. |
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. |
2014 |
Cancer Discov |
pmid:25182153
|
Saha SK et al. |
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer. |
2014 |
Nature |
pmid:25043045
|
Pope WB |
Intraoperative mass spectrometry of tumor metabolites. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25028494
|
Reitman ZJ et al. |
Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia. |
2014 |
J. Biol. Chem. |
pmid:24986863
|
Navis AC et al. |
Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG. |
2013 |
Acta Neuropathol Commun |
pmid:24252742
|
Wang JH et al. |
Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24082129
|
Pollyea DA et al. |
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels. |
2013 |
Leuk. Lymphoma |
pmid:22680765
|